On September 19th, Livzon Pharma (01513) invested 4,998,700 yuan to repurchase 127,200 A shares.
Lizhu Pharmaceuticals (01513) announced that the company will invest RMB 499.87 million on September 19, 2025.
LIVZON PHARMA (01513) announced that on September 19, 2025, the company spent 4,998,700 yuan to repurchase 127,200 A-shares, with a repurchase price of 39.08-39.63 yuan per share.
Related Articles
GAD Environmental Technology (300854.SZ) shareholder Liu Qingsong received a warning letter from the Shenzhen Securities Regulatory Bureau.
COMBA (02342) exercised its option to purchase shares, resulting in the issuance of 13.68 million shares.
CMST Development (600787.SH) plans to increase the capital of Zhongchuanghengke Internet of Things System Co., Ltd. through debt-to-equity conversion.
GAD Environmental Technology (300854.SZ) shareholder Liu Qingsong received a warning letter from the Shenzhen Securities Regulatory Bureau.
COMBA (02342) exercised its option to purchase shares, resulting in the issuance of 13.68 million shares.
CMST Development (600787.SH) plans to increase the capital of Zhongchuanghengke Internet of Things System Co., Ltd. through debt-to-equity conversion.
RECOMMEND
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025
Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025
